Qualitative Immunoglobulin Deficiency Causes Bacterial Infections in Patients with STAT1 Gain-of-Function Mutations.
Antibody Affinity
B cell
Gain of Function
IGH
Immunoglobulin Replacement Therapy
STAT1
Journal
Journal of clinical immunology
ISSN: 1573-2592
Titre abrégé: J Clin Immunol
Pays: Netherlands
ID NLM: 8102137
Informations de publication
Date de publication:
17 May 2024
17 May 2024
Historique:
received:
09
01
2024
accepted:
22
04
2024
medline:
17
5
2024
pubmed:
17
5
2024
entrez:
17
5
2024
Statut:
epublish
Résumé
STAT1 is a transduction and transcriptional regulator that functions within the classical JAK/STAT pathway. In addition to chronic mucocutaneous candidiasis, bacterial infections are a common occurrence in patients with STAT1 gain-of-function (GOF) mutations. These patients often exhibit skewing of B cell subsets; however, the impact of STAT1-GOF mutations on B cell-mediated humoral immunity remains largely unexplored. It is also unclear whether these patients with IgG within normal range require regular intravenous immunoglobulin (IVIG) therapy. Eleven patients (harboring nine different STAT1-GOF mutations) were enrolled. Reporter assays and immunoblot analyses were performed to confirm STAT1 mutations. Flow cytometry, deep sequencing, ELISA, and ELISpot were conducted to assess the impact of STAT1-GOF on humoral immunity. All patients exhibited increased levels of phospho-STAT1 and total STAT1 protein, with two patients carrying novel mutations. In vitro assays showed that these two novel mutations were GOF mutations. Three patients with normal total IgG levels received regular IVIG infusions, resulting in effective control of bacterial infections. Four cases showed impaired affinity and specificity of pertussis toxin-specific antibodies, accompanied by reduced generation of class-switched memory B cells. Patients also had a disrupted immunoglobulin heavy chain (IGH) repertoire, coupled with a marked reduction in the somatic hypermutation frequency of switched Ig transcripts. STAT1-GOF mutations disrupt B cell compartments and skew IGH characteristics, resulting in impaired affinity and antigen-specificity of antibodies and recurrent bacterial infections. Regular IVIG therapy can control these infections in patients, even those with normal total IgG levels.
Identifiants
pubmed: 38758476
doi: 10.1007/s10875-024-01720-x
pii: 10.1007/s10875-024-01720-x
doi:
Substances chimiques
STAT1 protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
124Subventions
Organisme : National Natural Science Foundation of China
ID : 82071845
Organisme : National Natural Science Foundation of China
ID : 82070135
Organisme : National Key Research and Development Program of China
ID : 2021YFC2700804
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Villarino AV, Kanno Y, O’Shea JJ. Mechanisms and consequences of Jak-STAT signaling in the immune system. Nat Immunol. 2017;18(4):374–84. https://doi.org/10.1038/ni.3691 .
doi: 10.1038/ni.3691
pubmed: 28323260
Zhang W, Chen X, Gao G, et al. Clinical Relevance of Gain- and Loss-of-Function Germline Mutations in STAT1: A Systematic Review. Front Immunol. 2021;12:654406. https://doi.org/10.3389/fimmu.2021.654406 .
doi: 10.3389/fimmu.2021.654406
pubmed: 33777053
pmcid: 7991083
Toubiana J, Okada S, Hiller J, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016;127(25):3154–64. https://doi.org/10.1182/blood-2015-11-679902 .
doi: 10.1182/blood-2015-11-679902
pubmed: 27114460
pmcid: 4920021
Chen X, Xu Q, Li X, et al. Molecular and Phenotypic Characterization of Nine Patients with STAT1 GOF Mutations in China. J Clin Immunol. 2020;40(1):82–95. https://doi.org/10.1007/s10875-019-00688-3 .
doi: 10.1007/s10875-019-00688-3
pubmed: 31686315
Asano T, Utsumi T, Kagawa R, Karakawa S, Okada S. Inborn errors of immunity with loss- and gain-of-function germline mutations in STAT1. Clin Exp Immunol. 2023;212(2):96–106. https://doi.org/10.1093/cei/uxac106 .
doi: 10.1093/cei/uxac106
pubmed: 36420581
Akkaya M, Kwak K, Pierce SK. B cell memory: building two walls of protection against pathogens. Nat Rev Immunol. 2020;20(4):229–38. https://doi.org/10.1038/s41577-019-0244-2 .
doi: 10.1038/s41577-019-0244-2
pubmed: 31836872
Laidlaw BJ, Cyster JG. Transcriptional regulation of memory B cell differentiation. Nat Rev Immunol. 2021;21(4):209–20. https://doi.org/10.1038/s41577-020-00446-2 .
doi: 10.1038/s41577-020-00446-2
pubmed: 33024284
Methot SP, Di Noia JM. Molecular Mechanisms of Somatic Hypermutation and Class Switch Recombination. Adv Immunol. 2017;133:37–87. https://doi.org/10.1016/bs.ai.2016.11.002 .
doi: 10.1016/bs.ai.2016.11.002
pubmed: 28215280
Gitlin AD, von Boehmer L, Gazumyan A, Shulman Z, Oliveira TY, Nussenzweig MC. Independent Roles of Switching and Hypermutation in the Development and Persistence of B Lymphocyte Memory. Immunity. 2016;44(4):769–81. https://doi.org/10.1016/j.immuni.2016.01.011 .
doi: 10.1016/j.immuni.2016.01.011
pubmed: 26944202
pmcid: 4838502
Viant C, Weymar GHJ, Escolano A, et al. Antibody Affinity Shapes the Choice between Memory and Germinal Center B Cell Fates. Cell. 2020;183(5):1298-1311.e11. https://doi.org/10.1016/j.cell.2020.09.063 .
doi: 10.1016/j.cell.2020.09.063
pubmed: 33125897
pmcid: 7722471
Roco JA, Mesin L, Binder SC, et al. Class-Switch Recombination Occurs Infrequently in Germinal Centers. Immunity. 2019;51(2):337-350.e7. https://doi.org/10.1016/j.immuni.2019.07.001 .
doi: 10.1016/j.immuni.2019.07.001
pubmed: 31375460
pmcid: 6914312
Kitaura K, Yamashita H, Ayabe H, Shini T, Matsutani T, Suzuki R. Different Somatic Hypermutation Levels among Antibody Subclasses Disclosed by a New Next-Generation Sequencing-Based Antibody Repertoire Analysis. Front Immunol. 2017;8:389. https://doi.org/10.3389/fimmu.2017.00389 .
doi: 10.3389/fimmu.2017.00389
pubmed: 28515723
pmcid: 5413556
Tangye SG, Pathmanandavel K, Ma CS. Cytokine-mediated STAT-dependent pathways underpinning human B-cell differentiation and function. Curr Opin Immunol. 2023;81:102286. https://doi.org/10.1016/j.coi.2023.102286 .
doi: 10.1016/j.coi.2023.102286
pubmed: 36764056
van Zelm MC, Bartol SJ, Driessen GJ, et al. Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation. J Allergy Clin Immunol. 2014;134(1):135–44. https://doi.org/10.1016/j.jaci.2013.11.015 .
doi: 10.1016/j.jaci.2013.11.015
pubmed: 24418477
Berkowska MA, Driessen GJ, Bikos V, et al. Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways. Blood. 2011;118(8):2150–8. https://doi.org/10.1182/blood-2011-04-345579 .
doi: 10.1182/blood-2011-04-345579
pubmed: 21690558
pmcid: 3342861
Macdonald RA, Hosking CS, Jones CL. The measurement of relative antibody affinity by ELISA using thiocyanate elution. J Immunol Methods. 1988;106(2):191–4. https://doi.org/10.1016/0022-1759(88)90196-2 .
doi: 10.1016/0022-1759(88)90196-2
pubmed: 3339255
Venselaar H, Te Beek TA, Kuipers RK, et al. Protein structure analysis of mutations causing inheritable diseases An e-Science approach with life scientist friendly interfaces. BMC Bioinformatics. 2010;11:548. https://doi.org/10.1186/1471-2105-11-548 .
doi: 10.1186/1471-2105-11-548
pubmed: 21059217
pmcid: 2992548
Kagawa R, Fujiki R, Tsumura M, et al. Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants. J Allergy Clin Immunol. 2017;140(1):232–41. https://doi.org/10.1016/j.jaci.2016.09.035 .
doi: 10.1016/j.jaci.2016.09.035
pubmed: 28011069
Itan Y, Shang L, Boisson B, et al. The mutation significance cutoff: gene-level thresholds for variant predictions. Nat Methods. 2016;13(2):109–10. https://doi.org/10.1038/nmeth.3739 .
doi: 10.1038/nmeth.3739
pubmed: 26820543
pmcid: 4980758
Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46(3):310–5. https://doi.org/10.1038/ng.2892 .
doi: 10.1038/ng.2892
pubmed: 24487276
pmcid: 3992975
Zhang P, Bigio B, Rapaport F, et al. PopViz: a webserver for visualizing minor allele frequencies and damage prediction scores of human genetic variations. Bioinformatics. 2018;34(24):4307–9. https://doi.org/10.1093/bioinformatics/bty536 .
doi: 10.1093/bioinformatics/bty536
pubmed: 30535305
pmcid: 6289133
Kitaura K, Yamashita H, Ayabe H, et al. Different Somatic Hypermutation Levels among Antibody Subclasses Disclosed by a New Next-Generation Sequencing-Based Antibody Repertoire Analysis. Front Immunol. 2017;8:389. https://doi.org/10.3389/fimmu.2017.00389 .
doi: 10.3389/fimmu.2017.00389
pubmed: 28515723
pmcid: 5413556
Ma CS, Wong N, Rao G, et al. Unique and shared signaling pathways cooperate to regulate the differentiation of human CD4+ T cells into distinct effector subsets. J Exp Med. 2016;213(8):1589–608. https://doi.org/10.1084/jem.20151467 .
doi: 10.1084/jem.20151467
pubmed: 27401342
pmcid: 4986526
Largent AD, Lambert K, Chiang K, et al. Dysregulated IFN-γ signals promote autoimmunity in STAT1 gain-of-function syndrome. Sci Transl Med. 2023;15(703):eade7028. https://doi.org/10.1126/scitranslmed.ade7028 .
doi: 10.1126/scitranslmed.ade7028
pubmed: 37406138
Ma CS, Wong N, Rao G, et al. Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies. J Allergy Clin Immunol. 2015;136(4):993-1006.e1. https://doi.org/10.1016/j.jaci.2015.05.036 .
doi: 10.1016/j.jaci.2015.05.036
pubmed: 26162572
pmcid: 5042203
Al Shehri T, Gilmour K, Gothe F, et al. Novel gain-of-function mutation in Stat1 sumoylation site leads to CMC/CID phenotype responsive to ruxolitinib. J Clin Immunol. 2019;39:776–85. https://doi.org/10.1007/s10875-019-00687-4 .
doi: 10.1007/s10875-019-00687-4
pubmed: 31512162
van Zelm MC, Bosco JJ, Aui PM, et al. Impaired STAT3-Dependent Upregulation of IL2Rα in B Cells of a Patient With a STAT1 Gain-of-Function Mutation. Front Immunol. 2019;10:768. https://doi.org/10.3389/fimmu.2019.00768 .
doi: 10.3389/fimmu.2019.00768
pubmed: 31068927
pmcid: 6491679
Smyth AE, Kaleviste E, Snow A, Kisand K, McMahon CJ, Cant AJ, et al. Aortic calcification in a patient with a gain-of-function STAT1 mutation. J Clin Immunol. 2018;38:468–70. https://doi.org/10.1007/s10875-018-0513-z .
doi: 10.1007/s10875-018-0513-z
pubmed: 29804236
Marinelli L, Ristagno E, Fischer P, Abraham R, Joshi A. Cryptococcal pneumonia in an adolescent with a gain-of-function variant in signal transduction and activator of transcription 1 (STAT1). BMJ Case Rep. 2020;13:e234120. https://doi.org/10.1136/bcr-2019-234120 .
doi: 10.1136/bcr-2019-234120
pubmed: 32327459
pmcid: 7202788
Hartono SP, Vargas-Hernández A, Ponsford MJ, et al. Novel STAT1 Gain-of-Function Mutation Presenting as Combined Immunodeficiency. J Clin Immunol. 2018;38(7):753–6. https://doi.org/10.1007/s10875-018-0554-3 .
doi: 10.1007/s10875-018-0554-3
pubmed: 30317461
Delmonte OM, Bergerson JRE, Burbelo PD, et al. Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity. J Allergy Clin Immunol. 2021;148(5):1192–7. https://doi.org/10.1016/j.jaci.2021.08.016 .
doi: 10.1016/j.jaci.2021.08.016
pubmed: 34492260
pmcid: 8418380
Chi X, Li Y, Qiu X. V(D)J recombination, somatic hypermutation and class switch recombination of immunoglobulins: mechanism and regulation. Immunology. 2020;160(3):233–47. https://doi.org/10.1111/imm.13176 .
doi: 10.1111/imm.13176
pubmed: 32031242
pmcid: 7341547
Horiuchi K, Imai K, Mitsui-Sekinaka K, et al. Analysis of somatic hypermutations in the IgM switch region in human B cells. J Allergy Clin Immunol. 2014;134(2):411–9. https://doi.org/10.1016/j.jaci.2014.02.043 .
doi: 10.1016/j.jaci.2014.02.043
pubmed: 24836470
Cagigi A, Misasi J, Ploquin A, et al. Vaccine Generation of Protective Ebola Antibodies and Identification of Conserved B-Cell Signatures. J Infect Dis. 2018;218:S528–36. https://doi.org/10.1093/infdis/jiy333 .
doi: 10.1093/infdis/jiy333
pubmed: 30010811
pmcid: 6455927
Avery DT, Deenick EK, Ma CS, et al. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J Exp Med. 2010;207(1):155–71. https://doi.org/10.1084/jem.20091706 .
doi: 10.1084/jem.20091706
pubmed: 20048285
pmcid: 2812540
Kirkham PM, Schroeder HW Jr. Antibody structure and the evolution of immunoglobulin V gene segments. Semin Immunol. 1994;6(6):347–60. https://doi.org/10.1006/smim.1994.1 .
doi: 10.1006/smim.1994.1
pubmed: 7654992